Notification of Major Interes

RNS Number : 7350I
The MedicX Fund Limited
17 March 2010
 



 




                   TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi



1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:
ii

 

   Medicx Fund Ltd

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights


An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached


An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments


An event changing the breakdown of voting rights

X

Other (please specify):

Increase in total voting rights following Placing, Open Offer and Offer for Subscription


3. Full name of person(s) subject to the
notification obligation:
iii

Smith & Williamson Investment Management Ltd

4. Full name of shareholder(s)
 (if different from 3.):iv

Nominee companies used by Smith and Williamson Investment Management as detailed in Section 9

5. Date of the transaction and date on
which the threshold is crossed or
reached:
v

12th March 2010

6. Date on which issuer notified:

17th March 2010

7. Threshold(s) that is/are crossed or
reached:
vi, vii

5%



 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of  voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

 

B1DVQL9

 

 

 

6,882,110

 

 

 

 

6,882,110

 

 

6,882,110

 


6,882,110

 


4.94%

 



B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Expiration
date
xiii

Exercise/
Conversion Period
xiv

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

% of voting
rights

N/A

N/A

N/A

N/A

N/A


C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial
instrument

Exercise price

Expiration date xvii

Exercise/
Conversion period
xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

N/A

N/A

N/A

N/A

N/A

Nominal

Delta

N/A

N/A


Total (A+B+C)

Number of voting rights

Percentage of voting rights

6,882,110

4.94%



 

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:
xxi

BNP Paribas as custodian for Smith & Williamson Investment Management Limited, a subsidiary of Smith & Williamson Holdings Ltd: 229,622 shares.

Smith & Williamson Nominees Limited, a subsidiary of Smith & Williamson Investment Management Limited, subsidiary of Smith and Williamson Holdings Limited: 6,652,488 shares


Proxy Voting:

10. Name of the proxy holder:

 

N/A  

11. Number of voting rights proxy holder will cease
to hold:

 

N/A  

12. Date on which proxy holder will cease to hold
voting rights:

 

N/A  



13. Additional information:

 

 

14. Contact name:

 

 

15. Contact telephone number:

 

 



 

Note: Annex should only be submitted to the FSA not the issuer

Annex: Notification of major interests in share


A: Identity of the persons or legal entity subject to the notification obligation

Full name

(including legal form of legal entities)

 

Steven Payne
Compliance Officer
Smith and Williamson Investment Management 

Contact address

(registered office for legal entities)

 


25 Moorgate, London, EC2R 6AY

Phone number & email

 

020 7131 4922

steven.payne@smith.williamson.co.uk

Other useful information

(at least legal representative for legal persons)

 




B: Identity of the notifier, if applicable

Full name

 


Contact address

 


Phone number & email

 


Other useful information

(e.g. functional relationship with the person or legal entity subject to the notification obligation)



C: Additional information

Notification disclosed following change to the number of shares in issue. Increase of 34,291,038 from 105,021,215 to 139,312,243.

For notes on how to complete form TR-1 please see the FSA website.

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLJRMTTMBABBFM
UK 100

Latest directors dealings